Bilhi Genetics Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Employees
  • 11

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 10

Bilhi Genetics General Information

Description

Developer of a genetic diagnostic technology designed to prevent cancer by identifying patients susceptible to developing serious illnesses before they occur. The company's genetic predictive technologies help to prevent fibrosis, cirrhosis, and cancers and enhance medical care, enabling physicians to diagnose and prevent cancer.

Contact Information

Website
www.bilhigenetics.com
Formerly Known As
GenePred
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 60 avenue Andre Roussin
  • CEDEX 16
  • 13321 Marseille
  • France
+33 04 00 00 00 00
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Other Healthcare Technology Systems
Biotechnology
Drug Discovery
Vertical(s)
Artificial Intelligence & Machine Learning, HealthTech, Life Sciences, Oncology
Corporate Office
  • 60 avenue Andre Roussin
  • CEDEX 16
  • 13321 Marseille
  • France
+33 04 00 00 00 00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Bilhi Genetics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC 01-Jan-2022 00.000 Completed Clinical Trials - General
7. Later Stage VC 19-Aug-2020 00000 00.000 0000 Completed Clinical Trials - General
6. Later Stage VC 18-Dec-2017 00.000 00.00 000.00 Completed Clinical Trials - General
5. Early Stage VC 01-Jul-2016 00000 00000 00.000 Completed Clinical Trials - General
4. Accelerator/Incubator 01-Jan-2016 00.000 Completed Startup
3. Equity Crowdfunding 03-Jul-2015 00.000 00.000 Completed Startup
2. Grant $93.4K Completed Startup
1. Accelerator/Incubator Completed Startup
To view Bilhi Genetics’s complete valuation and funding history, request access »

Bilhi Genetics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Ordinary Shares 00,000 00.000000 000.00 000.00 00 000.00 00.000
Ordinary Shares 000,000 00.000000 0000.00 0000.00 00 0000.00 0.000
Ordinary Shares 22,348 $1.175539 $23.49 $23.49 1x $23.49 67.04%
To view Bilhi Genetics’s complete cap table history, request access »

Bilhi Genetics Executive Team (7)

Name Title Board Seat
Pierre Dessein Co-Founder, Chief Executive Officer, President & Chairman
Stephane Lucchini Ph.D Chief Operating Officer & Managing Director
Alain Dessein Ph.D Co-Founder & Chief Strategy Officer
Annabelle Armand Chief Technology Officer
Bruno Dessein Co-Founder
You’re viewing 5 of 7 executive team members. Get the full list »

Bilhi Genetics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Bilhi Genetics Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
CapHorn Invest Venture Capital Minority 000 0000 000000 0
Sygma Accelerator/Incubator Minority 000 0000 000000 0
Colombe Investments Venture Capital Minority 000 0000 000000 0
Lise Invest Corporation Minority 000 0000 000000 0
Montgrand Wealth Partner Family Office Minority 000 0000 000000 0
You’re viewing 5 of 10 investors. Get the full list »

Ready to get started?

Request a free trial

Bilhi Genetics FAQs

  • When was Bilhi Genetics founded?

    Bilhi Genetics was founded in 2012.

  • Who is the founder of Bilhi Genetics?

    Pierre Dessein, Alain Dessein Ph.D, and Bruno Dessein are the founders of Bilhi Genetics.

  • Who is the CEO of Bilhi Genetics?

    Pierre Dessein is the CEO of Bilhi Genetics.

  • Where is Bilhi Genetics headquartered?

    Bilhi Genetics is headquartered in Marseille, France.

  • What is the size of Bilhi Genetics?

    Bilhi Genetics has 11 total employees.

  • What industry is Bilhi Genetics in?

    Bilhi Genetics’s primary industry is Discovery Tools (Healthcare).

  • Is Bilhi Genetics a private or public company?

    Bilhi Genetics is a Private company.

  • What is Bilhi Genetics’s current revenue?

    The current revenue for Bilhi Genetics is 000000.

  • How much funding has Bilhi Genetics raised over time?

    Bilhi Genetics has raised $3.57M.

  • Who are Bilhi Genetics’s investors?

    CapHorn Invest, Sygma, Colombe Investments, Lise Invest, and Montgrand Wealth Partner are 5 of 10 investors who have invested in Bilhi Genetics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »